About the American Cancer Society’s Research Program

The American Cancer Society’s research program was founded in 1946,
and has funded about $4 billion in cancer research since that time. The American Cancer Society is the largest non-profit, non-governmental source of cancer research funds in the United States, with an annual investment of approximately $130 million.

Scientists supported by the American Cancer Society have made great contributions. For example, they:

Established the link between cigarette smoking and lung cancer

Demonstrated the effectiveness of the Papanicolaou (Pap) smear in detecting cervical cancer at an early stage, decreasing deaths by more than 70 percent

Developed cancer-fighting drugs (5-FU) and biologic response modifiers (interferon)

Dramatically increased the cure rate for childhood leukemia to over 85 percent

Developed monoclonal antibodies to treat lymphoma and breast cancer

Showed the importance of estrogen receptors in breast cancer

Showed the proficiency of the estrogen antagonist, tamoxifen, in preventing breast cancer recurrence and reducing incidence in high-risk women

Proved the safety and effectiveness of mammograms

Proved the efficacy of lumpectomy plus radiation compared with mastectomy for some breast cancers

Created hormonal therapy for prostate cancer

Developed the prostate-specific antigen (PSA) screening test

Defined the role of new blood vessels (angiogenesis) in tumor growth

Defined the structure of DNA, the genetic material

Discovered cancer-causing genes and tumor suppressor genes

Discovered breast and colon cancer susceptibility genes

The success of the American Cancer Society's research program is exemplified by the fact that 46 Nobel Prize winners received grant support from the Society before they were awarded the prize.

American Cancer Society Research in Alabama

Crystal Broussard, MSW

University of Alabama at Tuscaloosa

Exploring Transitions from Curative Treatment to Hospice Care

07/01/2011 through 6/30/2013


Randall Davis, M.D.

University of Alabama at Birmingham

Defining the Functional Role of FcRH1 in B Cells

01/01/2008 through 12/31/2012


Jason Gertz, PhD

Hudson Alpha Institute for Biotechnology

Genomic Consequences of Environmental Estrogen Exposure in Cancer Cells

01/01/2012 through 12/31/2013


John L. Hartman, M.D.

University of Alabama at Birmingham

Molecular Buffering of dNTP Metabolism by Target of Rapamycin Signaling

01/01/2010 through 12/31/2013


Warner K. Huh, M.D.

University of Alabama at Birmingham

Development of HPV Vaccine for Global Prevention of Cervical Neoplasia

7/01/2008 through 06/30/2012


Douglas R. Hurst, PhD

University of Alabama at Birmingham

Composition of SIN3 Protein Complexes in Breast Cancer Metastasis

07/01/2011 through 06/30/2015


Elizabeth Kvale, MD

University of Alabama at Birmingham

Care Transitions in Cancer Survivorship

07/01/2011 through 6/30/2014


Edward E. Partridge, MD

University of Alabama at Birmingham

Institutional Research Grant

01/01/2012 through 12/31/2014



TOTAL GRANT MONEY = $3,579,911

Finding Cures in Alabama